The University of Chicago Header Logo

Connection

Godfrey Getz to Humans

This is a "connection" page, showing publications Godfrey Getz has written about Humans.
Connection Strength

0.674
  1. Insights from Murine Studies on the Site Specificity of Atherosclerosis. Int J Mol Sci. 2024 Jun 09; 25(12).
    View in: PubMed
    Score: 0.031
  2. ILRUNing to Atherosclerosis. Arterioscler Thromb Vasc Biol. 2022 09; 42(9):1152-1153.
    View in: PubMed
    Score: 0.027
  3. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 10; 31(5):286-290.
    View in: PubMed
    Score: 0.024
  4. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 02; 31(1):35-37.
    View in: PubMed
    Score: 0.023
  5. Apoprotein E and Reverse Cholesterol Transport. Int J Mol Sci. 2018 Nov 06; 19(11).
    View in: PubMed
    Score: 0.021
  6. Lipid Transfer Proteins: Introduction to the Thematic Review Series. J Lipid Res. 2018 05; 59(5):745-748.
    View in: PubMed
    Score: 0.020
  7. Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Curr Opin Lipidol. 2017 Oct; 28(5):403-407.
    View in: PubMed
    Score: 0.020
  8. Natural killer T cells in atherosclerosis. Nat Rev Cardiol. 2017 05; 14(5):304-314.
    View in: PubMed
    Score: 0.019
  9. Serum amyloid A and atherosclerosis. Curr Opin Lipidol. 2016 10; 27(5):531-5.
    View in: PubMed
    Score: 0.018
  10. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. J Lipid Res. 2016 05; 57(5):758-66.
    View in: PubMed
    Score: 0.018
  11. Atherogenic lipids and macrophage subsets. Curr Opin Lipidol. 2015 Oct; 26(5):357-61.
    View in: PubMed
    Score: 0.017
  12. Use of Mouse Models in Atherosclerosis Research. Methods Mol Biol. 2015; 1339:1-16.
    View in: PubMed
    Score: 0.016
  13. The structure/function of apoprotein A-I mimetic peptides: an update. Curr Opin Endocrinol Diabetes Obes. 2014 Apr; 21(2):129-33.
    View in: PubMed
    Score: 0.015
  14. Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2014 Apr; 34(4):695-6.
    View in: PubMed
    Score: 0.015
  15. PCSK9 in South African variants of familial hypercholesterolemia. J Am Coll Cardiol. 2014 Jun 10; 63(22):2374-5.
    View in: PubMed
    Score: 0.015
  16. Calpain inhibition as a potential treatment of Alzheimer's disease. Am J Pathol. 2012 Aug; 181(2):388-91.
    View in: PubMed
    Score: 0.014
  17. Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res. 2012 May; 53(5):951-963.
    View in: PubMed
    Score: 0.013
  18. Atherosclerosis: beyond cholesterol. Curr Opin Lipidol. 2011 Dec; 22(6):507-8.
    View in: PubMed
    Score: 0.013
  19. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thromb Haemost. 2011 Nov; 106(5):814-9.
    View in: PubMed
    Score: 0.013
  20. The ABC transporters and the thickening cholesterol plot. Curr Opin Lipidol. 2011 Feb; 22(1):72-3.
    View in: PubMed
    Score: 0.012
  21. High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010 Aug; 30(8):1497-9.
    View in: PubMed
    Score: 0.012
  22. Biological properties of apolipoprotein a-I mimetic peptides. Curr Atheroscler Rep. 2010 Mar; 12(2):96-104.
    View in: PubMed
    Score: 0.012
  23. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des. 2010; 16(28):3173-84.
    View in: PubMed
    Score: 0.011
  24. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol. 2009 Jun; 20(3):171-5.
    View in: PubMed
    Score: 0.011
  25. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res. 2009 Sep; 50(9):1889-900.
    View in: PubMed
    Score: 0.011
  26. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res. 2009 Mar; 50(3):376-385.
    View in: PubMed
    Score: 0.011
  27. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem. 2008 Jun 06; 283(23):15779-88.
    View in: PubMed
    Score: 0.010
  28. Overview of murine atherosclerosis series. Curr Drug Targets. 2007 Nov; 8(11):1144-9.
    View in: PubMed
    Score: 0.010
  29. Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2007 Dec; 27(12):2499-506.
    View in: PubMed
    Score: 0.010
  30. Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):237-9.
    View in: PubMed
    Score: 0.009
  31. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J Lipid Res. 2005 Jan; 46(1):1-10.
    View in: PubMed
    Score: 0.008
  32. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol. 2004 Jun; 15(3):261-7.
    View in: PubMed
    Score: 0.008
  33. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res. 2004 Jul; 45(7):1347-54.
    View in: PubMed
    Score: 0.008
  34. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004 Jan; 24(1):12-22.
    View in: PubMed
    Score: 0.007
  35. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. J Neurochem. 2003 Sep; 86(6):1391-402.
    View in: PubMed
    Score: 0.007
  36. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res. 2003 Apr; 44(4):780-92.
    View in: PubMed
    Score: 0.007
  37. Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. J Biol Chem. 2002 Nov 22; 277(47):45704-14.
    View in: PubMed
    Score: 0.007
  38. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem. 2002 Mar 22; 277(12):9645-54.
    View in: PubMed
    Score: 0.007
  39. The first human monoclonal antibody to oxidized LDL. Arterioscler Thromb Vasc Biol. 2001 Aug; 21(8):1254-5.
    View in: PubMed
    Score: 0.006
  40. When is atherosclerosis not atherosclerosis? Arterioscler Thromb Vasc Biol. 2000 Jun; 20(6):1694.
    View in: PubMed
    Score: 0.006
  41. Lipoproteins in the central nervous system. Ann N Y Acad Sci. 2000 Apr; 903:167-75.
    View in: PubMed
    Score: 0.006
  42. Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2019 12; 39(12):2457-2467.
    View in: PubMed
    Score: 0.006
  43. Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells. J Lipid Res. 1998 Jul; 39(7):1372-81.
    View in: PubMed
    Score: 0.005
  44. Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: studies before and after triglyceride-lowering therapy. Metabolism. 1998 Feb; 47(2):234-42.
    View in: PubMed
    Score: 0.005
  45. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid. J Neurosci Res. 1997 Jul 01; 49(1):9-18.
    View in: PubMed
    Score: 0.005
  46. Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett. 2016 08; 590(16):2650-60.
    View in: PubMed
    Score: 0.004
  47. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1101-13.
    View in: PubMed
    Score: 0.004
  48. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells. J Biol Chem. 1996 Mar 15; 271(11):6062-70.
    View in: PubMed
    Score: 0.004
  49. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res. 2016 Feb; 57(2):246-57.
    View in: PubMed
    Score: 0.004
  50. Heparin-induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particles. J Lipid Res. 1994 Dec; 35(12):2178-90.
    View in: PubMed
    Score: 0.004
  51. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene. 2014 Nov 06; 33(45):5295-302.
    View in: PubMed
    Score: 0.004
  52. Inhibition of apolipoprotein E degradation in a post-Golgi compartment by a cysteine protease inhibitor. J Biol Chem. 1993 Apr 25; 268(12):8497-502.
    View in: PubMed
    Score: 0.004
  53. Report on the workshop on diabetes and mechanisms of atherogenesis. September 17th and 18th, 1992, Bethesda, Maryland. Arterioscler Thromb. 1993 Mar; 13(3):459-64.
    View in: PubMed
    Score: 0.004
  54. Human plasma lipoproteins regulate apolipoprotein E secretion from a post-Golgi compartment. J Biol Chem. 1992 Oct 25; 267(30):21961-6.
    View in: PubMed
    Score: 0.003
  55. Preferential interactions between ApoE-containing lipoproteins and Aß revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim Biophys Acta. 2012 Feb; 1821(2):295-302.
    View in: PubMed
    Score: 0.003
  56. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 2011 Oct 11; 58(16):1715-27.
    View in: PubMed
    Score: 0.003
  57. Nonlysosomal cytoplasmic degradation. J Submicrosc Cytol Pathol. 1991 Jul; 23(3):491-500.
    View in: PubMed
    Score: 0.003
  58. Aspen Hepatic Cholesterol and Lipoprotein Conference 1989. Report of a conference. J Lipid Res. 1990 Jul; 31(7):1327-33.
    View in: PubMed
    Score: 0.003
  59. An overview of atherosclerosis: a look to the future. Toxicol Pathol. 1990; 18(4 Pt 1):623-35.
    View in: PubMed
    Score: 0.003
  60. The involvement of lipoproteins in atherogenesis. Evolving concepts. Ann N Y Acad Sci. 1990; 598:17-28.
    View in: PubMed
    Score: 0.003
  61. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A. 2009 Mar 24; 106(12):4834-9.
    View in: PubMed
    Score: 0.003
  62. Mechanism of the growth-related activation of the low density lipoprotein receptor pathway. J Biol Chem. 1989 Jan 25; 264(3):1787-92.
    View in: PubMed
    Score: 0.003
  63. Atherosclerosis and apoprotein E. An enigmatic relationship. Arch Pathol Lab Med. 1988 Oct; 112(10):1048-55.
    View in: PubMed
    Score: 0.003
  64. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther. 2008 Nov; 327(2):332-42.
    View in: PubMed
    Score: 0.003
  65. Macrophage free cholesterol content regulates apolipoprotein E synthesis. J Biol Chem. 1987 Aug 25; 262(24):11657-62.
    View in: PubMed
    Score: 0.002
  66. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science. 2007 Apr 13; 316(5822):285-8.
    View in: PubMed
    Score: 0.002
  67. Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 2006 Jan 17; 45(2):381-90.
    View in: PubMed
    Score: 0.002
  68. Molecular and cell biology of lipoprotein biosynthesis. Methods Enzymol. 1986; 128:41-70.
    View in: PubMed
    Score: 0.002
  69. Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. J Clin Invest. 1985 Aug; 76(2):816-25.
    View in: PubMed
    Score: 0.002
  70. Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. J Clin Endocrinol Metab. 1985 Jan; 60(1):203-7.
    View in: PubMed
    Score: 0.002
  71. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). J Biol Chem. 2003 Dec 26; 278(52):52841-7.
    View in: PubMed
    Score: 0.002
  72. Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7853-8.
    View in: PubMed
    Score: 0.002
  73. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. Biochem J. 2002 Aug 15; 366(Pt 1):273-9.
    View in: PubMed
    Score: 0.002
  74. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice. Biochemistry. 2001 Nov 13; 40(45):13670-80.
    View in: PubMed
    Score: 0.002
  75. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem Int. 2001 Nov-Dec; 39(5-6):427-34.
    View in: PubMed
    Score: 0.002
  76. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 2001 Apr 26; 20(18):2225-34.
    View in: PubMed
    Score: 0.002
  77. SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides. Biochemistry. 2000 Dec 26; 39(51):16119-24.
    View in: PubMed
    Score: 0.002
  78. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem. 1999 Oct 15; 274(42):30001-7.
    View in: PubMed
    Score: 0.001
  79. The synthesis and metabolism of the lipoproteins implicated in atherosclerosis. Artery. 1979 Apr; 5(4):330-45.
    View in: PubMed
    Score: 0.001
  80. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci. 1998 Jan 01; 18(1):195-204.
    View in: PubMed
    Score: 0.001
  81. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res. 1997 Nov; 42(5):651-5.
    View in: PubMed
    Score: 0.001
  82. Abnormalities of the arterial wall and its metabolism in atherogenesis. Prog Cardiovasc Dis. 1976 Mar-Apr; 18(5):341-69.
    View in: PubMed
    Score: 0.001
  83. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J Neuropathol Exp Neurol. 1996 Mar; 55(3):372-80.
    View in: PubMed
    Score: 0.001
  84. Letter: Sialylation in antitrypsin deficiency. N Engl J Med. 1975 May 08; 292(19):1031-2.
    View in: PubMed
    Score: 0.001
  85. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem. 1995 Apr 21; 270(16):9039-42.
    View in: PubMed
    Score: 0.001
  86. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 1994 Sep 23; 269(38):23403-6.
    View in: PubMed
    Score: 0.001
  87. Metabolic mechanisms for responses to dietary cholesterol and fat in high and low LDL responding baboons (Papio sp.). J Lipid Res. 1994 Apr; 35(4):633-43.
    View in: PubMed
    Score: 0.001
  88. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab. 1992 Aug; 75(2):465-71.
    View in: PubMed
    Score: 0.001
  89. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab. 1991 Apr; 72(4):934-44.
    View in: PubMed
    Score: 0.001
  90. Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement. Diabetologia. 1991 Apr; 34(4):253-9.
    View in: PubMed
    Score: 0.001
  91. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab. 1990 Oct; 71(4):1041-50.
    View in: PubMed
    Score: 0.001
  92. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation. 1990 May; 81(5):1721-33.
    View in: PubMed
    Score: 0.001
  93. A dynamic pathology of arterosclerosis. Am J Med. 1969 May; 46(5):657-73.
    View in: PubMed
    Score: 0.001
  94. A dynamic pathology of arteriosclerosis. Am J Med. 1969 May; 46(5):657-73.
    View in: PubMed
    Score: 0.001
  95. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Arteriosclerosis. 1984 Sep-Oct; 4(5):472-8.
    View in: PubMed
    Score: 0.000
  96. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation. Oncodev Biol Med. 1980; 1(4-5):273-85.
    View in: PubMed
    Score: 0.000
  97. Leukocyte mitochondria: function and biogenesis. Enzyme. 1972; 13(1):56-76.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.